Peter Buchwald, Ph.D., is an Assistant Professor at the Department of Molecular and Cellular Pharmacology and the Director of the Drug Discovery Program at the Diabetes Research Institute.
Dr. Buchwald obtained his doctorate from the University of Florida. He has worked in multi-disciplinary fields related to drug design and development both in the academic and industrial settings.
Dr. Buchwald has published numerous articles in peer-reviewed journals focused on the physicochemical and metabolic aspects of drug design and drug action, as well as on computer-aided quantitative modeling.
Coming from the pharmaceutical industry, Dr. Buchwald is directing the DRI's efforts aimed at developing safer and more effective drugs for islet replacement therapies.